Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wendland

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Klinische Monatsblatter Fur Augenheilkunde|August 1, 1974
[The use of carbactol instead of acetylcholine for syringing the anterior chamber in intraocular interventions to attain miosis (author's transl)]E N Hinzpeter, G Wendland
Herz|February 1, 2002
[Cost effectiveness of lipid lowering therapy]G Wendland, G Klever-Deichert, K Lauterbach
Zeitschrift Fur Kardiologie|November 20, 2002
[Cost-effectiveness of coronary heart disease prevention]G Wendland, G Klever-Deichert, K Lauterbach
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2000
[Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective]G Klever-Deichert, B Hinzpeter, G Wendland, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 6, 2004
Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT StudyH Hauner, M Meier, G Wendland, et al.
Herz|September 19, 2000
[Coronary disease and social security. A simulation model on cost analysis]B Hinzpeter, G Klever-Deichert, G Wendland, et al.
Herz|September 19, 2000
[Stent implantation as initial coronary interventional therapy? A theoretical model on clinical and economical consequences of in-stent restenosis]A Pfund, G Wendland, F Baer, et al.
The European Respiratory Journal|January 11, 2005
Asthma: prevalence and cost of illnessS Stock, M Redaelli, M Luengen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 24, 2006
Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in GermanyS A K Stock, M Redaelli, G Wendland, et al.
Zeitschrift Fur Kardiologie|October 27, 2001
[Coronary intervention and occupational rehabilitation--a prospective, randomized intervention study]A Pfund, J Pütz, G Wendland, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Klinische Monatsblatter Fur Augenheilkunde|August 1, 1974
[The use of carbactol instead of acetylcholine for syringing the anterior chamber in intraocular interventions to attain miosis (author's transl)]E N Hinzpeter, G Wendland
Herz|February 1, 2002
[Cost effectiveness of lipid lowering therapy]G Wendland, G Klever-Deichert, K Lauterbach
Zeitschrift Fur Kardiologie|November 20, 2002
[Cost-effectiveness of coronary heart disease prevention]G Wendland, G Klever-Deichert, K Lauterbach
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2000
[Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective]G Klever-Deichert, B Hinzpeter, G Wendland, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 6, 2004
Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT StudyH Hauner, M Meier, G Wendland, et al.
Herz|September 19, 2000
[Coronary disease and social security. A simulation model on cost analysis]B Hinzpeter, G Klever-Deichert, G Wendland, et al.
Herz|September 19, 2000
[Stent implantation as initial coronary interventional therapy? A theoretical model on clinical and economical consequences of in-stent restenosis]A Pfund, G Wendland, F Baer, et al.
The European Respiratory Journal|January 11, 2005
Asthma: prevalence and cost of illnessS Stock, M Redaelli, M Luengen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 24, 2006
Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in GermanyS A K Stock, M Redaelli, G Wendland, et al.
Zeitschrift Fur Kardiologie|October 27, 2001
[Coronary intervention and occupational rehabilitation--a prospective, randomized intervention study]A Pfund, J Pütz, G Wendland, et al.
Pageof 2